| Paolo L Peghini, MD | |
|
400 Savannah Rd, Suite B, Lewes, DE 19958-1499 | |
| (302) 645-3555 | |
| (302) 644-3560 |
| Full Name | Paolo L Peghini |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 35 Years |
| Location | 400 Savannah Rd, Lewes, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558379446 | NPI | - | NPPES |
| 0001053201 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | C10005923 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
| Beebe Medical Center | Lewes, DE | Hospital |
| Medstar Georgetown University Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beebe Physician Network Inc. | 5496744864 | 208 |
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that its wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem US$445.0 million aggregate principal amount of its outstanding 6.875% Senior Notes due 2018, CUSIP Nos. 91911XAN4, U9098VAF9 (the "Notes") on December 29, 2014 and has mailed an irrevocable notice of redemption for the Notes.
Bochum's medics have succeeded in treating cerebral palsy with autologous cord blood. Following a cardiac arrest with severe brain damage, a 2.5 year old boy had been in a persistent vegetative state - with minimal chances of survival. Just two months after treatment with the cord blood containing stem cells, the symptoms improved significantly; over the following months, the child learned to speak simple sentences and to move.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
› Verified 2 days ago
| Entity Name | Beebe Physician Network Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133992 PECOS PAC ID: 5496744864 Enrollment ID: O20040511000133 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that its wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem US$445.0 million aggregate principal amount of its outstanding 6.875% Senior Notes due 2018, CUSIP Nos. 91911XAN4, U9098VAF9 (the "Notes") on December 29, 2014 and has mailed an irrevocable notice of redemption for the Notes.
Bochum's medics have succeeded in treating cerebral palsy with autologous cord blood. Following a cardiac arrest with severe brain damage, a 2.5 year old boy had been in a persistent vegetative state - with minimal chances of survival. Just two months after treatment with the cord blood containing stem cells, the symptoms improved significantly; over the following months, the child learned to speak simple sentences and to move.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paolo L Peghini, MD 33663 Bayview Medical Dr, Unit 2, Lewes, DE 19958-1663 Ph: (302) 645-3555 | Paolo L Peghini, MD 400 Savannah Rd, Suite B, Lewes, DE 19958-1499 Ph: (302) 645-3555 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that its wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem US$445.0 million aggregate principal amount of its outstanding 6.875% Senior Notes due 2018, CUSIP Nos. 91911XAN4, U9098VAF9 (the "Notes") on December 29, 2014 and has mailed an irrevocable notice of redemption for the Notes.
Bochum's medics have succeeded in treating cerebral palsy with autologous cord blood. Following a cardiac arrest with severe brain damage, a 2.5 year old boy had been in a persistent vegetative state - with minimal chances of survival. Just two months after treatment with the cord blood containing stem cells, the symptoms improved significantly; over the following months, the child learned to speak simple sentences and to move.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
› Verified 2 days ago
Dr. George M. Kluchnik, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 | |
Amulya D Amirneni, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 17005 Old Orchard Rd, Lewes, DE 19958 Phone: 302-703-4025 | |
Dr. Steven A Calamita, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Dr. Maneshkumar F. Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 Savannah Rd, Suite B, Lewes, DE 19958 Phone: 302-645-3555 | |
Robert C Deckmann, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 33663 Bayview Medical Dr, Unit 2, Lewes, DE 19958 Phone: 302-645-9325 Fax: 302-645-5214 | |
Harry J Anagnostakos, DO Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 400 Savannah Rd, Suite B, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 | |
Dr. Carlton Boxhill, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1526 Savannah Rd, Lewes, DE 19958 Phone: 302-645-2244 Fax: 302-645-1173 |